Utility Study in Diffuse Large B-Cell Lymphoma (DLBCL)

Roche

Status: Completed

Conditions: Diffuse Large B-Cell Lymphoma

Study type: Observational

Funder types: Industry

Identifiers

NCT02708732

ML29956

Details and patient eligibility

About

This study is a prospective, cross-sectional survey to be administered to real patients in remission from DLBCL using a 15-minute postal or online survey. The project is designed to describe the impact of DLBCL remission on health utility and quality of life. Data collection will occur over a 4-month period.

Enrollment: 91 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adults greater than or equal to (>/=) 18 years of age
• Diagnosis of DLBCL and currently in first remission
• Prior drug treatment for DLBCL

Exclusion criteria

• Receiving active treatment for DLBCL
• Relapsed following any treatment for DLBCL

Trial design

91 participants in 1 patient group

DLBCL Participants

Description:

A cohort of approximately 100 patients in first remission with DLBCL will complete questionnaires through a 15-minute postal or online survey.